The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined analysis of three randomized phase III trials comparing S-1 monotherapy and S-1 combination therapy for first-line treatment of advanced gastric cancer.
 
Madoka Takeuchi
No Relationships to Disclose
 
Wataru Ichikawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Nippon Kayaku; Sawai Pharmaceutical Co; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Merck Serono; Ono Pharmaceutical; Zeria Pharmaceutical
Research Funding - Eisai; Taiho Pharmaceutical; Takeda
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Kohei Shitara
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Novartis; Sanofi; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Bayer (Inst); Chugai Pharma (Inst); Lilly (Inst); Takeda (Inst)
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); MSD (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Yu Sunakawa
Honoraria - Chugai Pharma; Kyowa Hakko Kirin; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Yakult Honsha (Inst)
 
Koji Oba
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Ono Pharmaceutical; Takeda
 
Hirofumi Michimae
No Relationships to Disclose
 
Everardo D. Saad
No Relationships to Disclose
 
Wasaburo Koizumi
No Relationships to Disclose
 
Yuh Sakata
Honoraria - Daiichi Sankyo; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Daiichi Sankyo; Otsuka; Taiho Pharmaceutical
 
Hiroshi Furukawa
No Relationships to Disclose
 
Marc E. Buyse
Employment - IDDI
Stock and Other Ownership Interests - IDDI
 
Masahiro Takeuchi
Honoraria - Mitsubishi Tanabe Pharma
Consulting or Advisory Role - Abbvie; AstraZeneca Japan; Hisamitsu Pharmaceutical; Kowa; Shionogi; Taiho Pharmaceutical
Travel, Accommodations, Expenses - AnGes
 
Masashi Fujii
Stock and Other Ownership Interests - Otsuka (I)
Consulting or Advisory Role - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization
 
Toshifusa Nakajima
Honoraria - Taiho Pharmaceutical